What MangoRx does

MangoRx, operated by Mangoceuticals, Inc. (NASDAQ: MGRX), is a Dallas-based direct-to-consumer telehealth platform serving U.S. men with prescription treatments for erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance. The company connects patients with licensed U.S. medical providers via a 100% online questionnaire-to-delivery flow, with prescriptions fulfilled by a Texas-based partner compounding pharmacy holding URAC, ACHC-PCAB, and LegitScript credentials, and shipped discreetly via UPS. Its proprietary technology stack is built around oral dissolving tablet (ODT) delivery—a sublingual format that achieves onset in as little as 10 minutes versus up to an hour for traditional pills—combined with novel multi-ingredient compounded formulations such as MangoMax (Sildenafil+Tadalafil+Oxytocin+Naltrexone), Pump (Tadalafil+Agmatine Sulfate), Grow (Minoxidil+Finasteride+Biotin+D3), and Slim (Semaglutide+Vitamin B6).

The business model is predominantly subscription/recurring revenue, anchored by the $99/month all-inclusive injectable TRT program launched in December 2025 (reported 336% MoM sales growth) and the $499/month GLP-1 obesity program (MangoRx Direct/PeachesRx Direct) launched November 2025 via access to LillyDirect and NovoCare channels. Per-tablet products (ED at $12.50, Pump at $2.50, Grow at $3.00) are sold through the proprietary e-commerce site with Subscribe and Save auto-refills at 10% discount. Free provider visits, no insurance requirement, and no mandatory subscription lower customer friction. The company also operates a wholly-owned subsidiary Mango DAT, LLC managing a Solana-focused Digital Asset Treasury strategy of up to $100M, and holds a PCT patent filing for MGX-0024 antiviral animal feed technology developed with IntraMont Technologies.

Operationally, the company remains small (1-10 employees), reported Q3 2023 revenue of $361,661 (29% YoY decline) with $17.9M in net losses, and has raised approximately $3.7M cumulatively across two post-IPO offerings in December 2023 ($1.2M) and December 2025 ($2.5M). It is engaged in a $73M lawsuit against former technology vendor Clarity Ventures, following disengagement and in-house platform development.

Name

MangoRx

Legal name

Mangoceuticals, Inc.

Website

https://mangorx.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

MangoRx is a Dallas-based direct-to-consumer telehealth platform that connects U.S. men with licensed providers for prescription compounded oral dissolving tablet treatments for erectile dysfunction, testosterone replacement, hair loss, weight loss, and performance enhancement.

Ownership category

akta.pro rank

Product category

Men's Telehealth

NAICS

Offices of Other Health Practitioners (6213), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

akta.pro secondary industries

Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

Keywords

• Men's telehealth services
• Erectile dysfunction treatment
• Testosterone replacement therapy
• Hair loss treatment
• Weight management medications

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Marketing or Sales, Supply Chain, Technology or R&D, Personnel, Operations

Revenue model

1. Testosterone Replacement Therapy (TRT) Program: All-inclusive injectable Testosterone Replacement Therapy program priced at $99 per month, generating monthly recurring revenue per customer. Launched mid-December with 336% month-over-month sales growth reported. Company expects TRT to be its primary growth driver.
2. Erectile Dysfunction Medications (Mango – Sildenafil, Tadalafil, MangoMax): Individual ED tablets sold at $12.50 per tablet in packs of 6, 12, or 18. Optional Subscribe and Save provides 10% discount and auto-refills processed every 25 days. MangoMax combines Tadalafil and Sildenafil in one formula.
3. Pump (Tadalafil + Agmatine Sulfate): Pre-workout/performance product sold at $2.50 per tablet, available in 30-day, 60-day, or 90-day supply packs. Subscribe and Save provides 10% discount on initial and all subsequent auto-refill orders.
4. Grow Hair Loss Treatment: Hair growth chewable tablets at $3 per tablet, with 30-day, 60-day, or 90-day supply options. Subscribe and Save includes free UPS Ground shipping and 10% discount on auto-refill orders.
5. Slim Weight Loss (Semaglutide ODT): Oral dissolving Semaglutide tablets for weight management. No explicit per-tablet price listed publicly; consultation at $99/month with personalized care plans.
6. GLP-1 Weight Management Programs (MangoRx Direct & PeachesRx Direct): Access to branded GLP-1 medications (Zepbound, Wegovy) at $499/month starting price plus $99/month membership fee, with no insurance required. Prescriptions facilitated through a third-party provider.
7. Digital Asset Treasury Strategy: Mangoceuticals launched Mango DAT, LLC as a newly formed subsidiary partnering with Cube Group to manage an up to $100 million Solana-focused Digital Asset Treasury strategy with target yields of 7-8% APY on staked SOL.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

MangoRx operates a 100% online men's telehealth platform that connects individual male patients with licensed U.S. medical providers via online questionnaires and consultations, then dispenses personalized compounded prescription medications through an in-network pharmacy shipped directly to the patient's home. The product portfolio centers on proprietary oral dissolving tablet (ODT) formulations across erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance, supplemented by telehealth-mediated access to branded GLP-1 medications (Zepbound, Wegovy).

Product overview

MangoRx is a men's health telehealth platform operating as a single unified offering with multiple treatment modules. The platform connects patients with licensed healthcare providers via online consultations and ships prescription medications from a certified partner pharmacy. The product portfolio spans five core treatment categories: (1) Erectile dysfunction treatments comprising MangoMax (Sildenafil+Tadalafil combination), Mango Sildenafil, and Mango Tadalafil as oral dissolving tablets; (2) Testosterone Replacement Therapy (TRT) as an injectable program; (3) Hair loss treatment via Grow chewable tablets; (4) Weight management through Slim oral dissolving tablets with Semaglutide; and (5) Performance enhancement via Pump tablets. Additionally, MangoRx Direct and PeachesRx Direct programs provide access to branded GLP-1 medications (Zepbound and Wegovy) sourced from Eli Lilly and Novo Nordisk respectively.

Differentiator

Problem solved

Functional benefit

Brands

• MangoMax: ED treatment combining Sildenafil and Tadalafil for both fast-acting and long-lasting performance with Oxytocin and Naltrexone
• Mango Sildenafil
• Mango Tadalafil
• Grow
• Pump
• Slim
• Prime
• MangoRx Direct
• PeachesRx Direct

Products and services

• MangoMax Oral dissolving tablet for erectile dysfunction combining Tadalafil and Sildenafil with Oxytocin and Naltrexone, designed to activate in as little as 10 minutes and provide both fast-acting and long-lasting performance for adult men.
• Mango Sildenafil Sublingual oral dissolving tablet combining Sildenafil with Oxytocin and L-Arginine for erectile dysfunction, available in 50mg or 100mg dosages; activates in approximately 10 minutes with effects lasting up to 4 hours.
• Mango Tadalafil Sublingual oral dissolving tablet combining Tadalafil with Oxytocin and L-Arginine for erectile dysfunction, available in 10mg or 20mg dosages; provides long-lasting effects up to 36 hours.
• Testosterone Replacement Therapy (TRT) Program $99/month all-inclusive injectable testosterone replacement therapy subscription including physician review, blood panel assessment, and ongoing monitoring for men with low testosterone.
• Grow Daily chewable mint-flavored tablet for male pattern baldness combining Minoxidil (2.5mg), Finasteride (1mg), Biotin (1mg), and Vitamin D3 (2000 IU); available in 30/60/90-day supply packs with Subscribe and Save 10% discount.
• Slim Oral dissolving tablet containing compounded Semaglutide (1–6mg) with Vitamin B6 for daily weight management, providing a needle-free oral GLP-1 alternative that mimics GLP-1 hormones to reduce appetite and caloric intake.
• Pump Daily oral dissolving tablet combining Tadalafil and Agmatine Sulfate for pre-workout performance, supporting nitric oxide signaling, healthy blood flow, muscle pumps, and recovery without caffeine-related jitters or crashes.
• MangoRx Direct Telehealth subscription program providing access to FDA-approved branded GLP-1 medications (Eli Lilly's Zepbound) for obesity management, priced at $499/month starting plus $99/month membership fee, with no insurance required and fulfillment through partner pharmacy channels including LillyDirect.
• PeachesRx Direct Telehealth weight management subscription program providing access to FDA-approved branded GLP-1 medications (Novo Nordisk's Wegovy) for obesity management, priced at $499/month starting plus $99/month membership fee, with no insurance required and fulfillment through partner pharmacy channels including NovoCare.

Quantifiable outcome

• 336% month-over-month sales growth for injectable TRT program since mid-December launch
• +6 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• IntraMont Technologies, Inc.coreStrategic or Co-development Partner · 26 February 2026Mangoceuticals entered into a partnership with IntraMont Technologies, Inc. to co-develop the MGX-0024 antiviral animal feed and drinking water additive technology. A PCT international patent application was filed on February 26, 2026, to secure global IP protection. Field trials across 29,000 birds demonstrated zero respiratory-related mortality and statistically significant H5N1 protection.
• Eli LillycoreChannel Partner/ Reseller/ Distributor · 13 November 2025MangoRx Direct and PeachesRx Direct programs provide access to Eli Lilly's Zepbound (tirzepatide) GLP-1 medication for obesity management at $499/month starting price plus $99/month membership fee. No direct contractual relationship exists; prescriptions facilitated through a third-party provider and fulfillable at LillyDirect and other licensed pharmacies.
• Novo NordiskcoreChannel Partner/ Reseller/ Distributor · 13 November 2025MangoRx Direct and PeachesRx Direct programs provide access to Novo Nordisk's Wegovy (semaglutide) GLP-1 medication for obesity management at $499/month starting price plus $99/month membership fee. No direct contractual relationship exists; prescriptions facilitated through a third-party provider and fulfillable at NovoCare and other licensed pharmacies.
• Clarity VenturesminorOthersClarity Ventures was a former technology consulting and software development firm engaged to build a HIPAA-compliant enterprise eCommerce platform. Mangoceuticals filed a $73 million lawsuit against Clarity Ventures alleging failure to deliver a compliant platform. Clarity denied allegations and asserted counterclaims. Mangoceuticals subsequently developed an in-house proprietary telehealth platform.
• Epiq Scripts, LLCcoreImplementation/ SI/ Consulting PartnerEpiq Scripts, LLC serves as the pharmacy partner for prescription fulfillment services through MangoRx's telehealth platform. MangoRx operates as a technology platform connecting users to prescription fulfillment services through Epiq Scripts.
• LabCorpminorChannel Partner/ Reseller/ DistributorMangoRx offers LabCorp testing through the platform for in-person blood work visits required for testosterone support protocols. Bloodwork must include Total Testosterone, Free Testosterone, SHBG, PSA, FSH, and Estradiol panels within 30 days.
• SpotDXminorChannel Partner/ Reseller/ DistributorMangoRx partners with SpotDX to provide an at-home dried blood sample kit for testosterone support blood panels at $75. Both options include all approved blood panels required for TRT protocols.
• Tasso+minorChannel Partner/ Reseller/ DistributorMangoRx partners with Tasso+ to provide a capillary sample at-home blood kit for testosterone support protocols at $100 (preferred option). The Tasso+ kit provides all approved blood panels required for TRT protocols.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Keeps: DTC men's telehealth brand focused on hair loss treatment (Finasteride, Minoxidil). Directly comparable to MangoRx's Grow product line in both category and cash-pay model.
• Ro (Roman): DTC men's telehealth platform historically focused on ED (Roman) and now spanning testosterone, hair, weight loss, and fertility. Directly comparable subscription model, condition-specific modules, and compounded offerings.
• BlueChew: DTC telehealth platform specializing in compounded Sildenafil/Tadalafil chewable tablets for ED. Closely comparable business model and pharmacy-fulfillment approach to MangoRx's ED product line.
• Hims & Hers Health: Largest direct-to-consumer telehealth platform for men's (and women's) health covering ED, hair loss, weight loss, and primary care. Closest direct competitor with public-comparable scale and a similar cash-pay subscription model.

Broad incumbents

• Teladoc Health: Largest US telehealth incumbent offering virtual care across many specialties. Overlaps MangoRx at the telehealth delivery mechanism and provider network layer, though MangoRx is more DTC-focused.
• GoodRx: Public digital health platform providing telehealth and prescription drug discounts. Broader incumbent that competes with MangoRx on cash-pay prescription affordability and online pharmacy access.

Emerging players

• LifeMD: DTC telehealth company offering men's hormone therapy, weight management, and primary care with subscription programs. Comparable cash-pay telehealth model and category breadth.
• Alpha Male Plus / Hone Health: DTC men's hormone optimization and TRT telehealth platform with at-home diagnostics. Directly comparable to MangoRx's TRT offering and similar subscription pricing model.
• Vault Health: Telehealth platform offering testosterone replacement therapy and men's hormone optimization with at-home diagnostics. Closely comparable to MangoRx's TRT/Prime program with similar clinical workflow.
• PeterMD: Men's telehealth brand offering ED, testosterone, and hair loss treatments via cash-pay subscription. Comparable niche DTC men's health positioning but smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MangoRx